Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed.

In contrast, in the group receiving 50 mg vildagliptin daily, more than two-thirds of patients experienced meaningful (37.8%) or marked (29.4%) improvement in glycemic control. In the group ...